1. Lam ACL, Hueniken K, Pienkowski M, Lee JJW, Dong M, Diergaarde B, Olshan AF, Brennan P, Virani S, Saunders D et al: Performance of 8 Smoking Metrics for Modeling Survival in Head and Neck Squamous Cell Carcinoma. JAMA Otolaryngology–Head & Neck Surgery 2025.

2. Thakral A, Lee JJ, Hou T, Hueniken K, Dudding T, Gormley M, Virani S, Olshan A, Diergaarde B, Ness AR et al: Smoking and alcohol by HPV status in head and neck cancer: a Mendelian randomization study. Nat Commun 2024, 15(1):7835.

3. Schmid S, Garcia M, Zhan L, Cheng S, Khan K, Chowdhury M, Sabouhanian A, Herman J, Walia P, Strom E et al: Outcomes with non-small cell lung cancer and brain-only metastasis. Heliyon 2024, 10(17):e37082.

4. Lee JJ, Alamleh S, Zhan LJ, Hueniken K, Mahler MB, Billfalk-Kelly A, Davies J, Brown MC, Spreafico A, Huang SH et al: Clinical Predictors of Cisplatin Chemoradiation-Induced Ototoxicity in HPV-Positive Oropharyngeal Squamous Cell Carcinoma: A Case-Control Study. J Otolaryngol Head Neck Surg 2024, 53:19160216241248671.

5. Ghazali N, Feng J, Hueniken K, Khan K, Balaratnam K, Waddell TK, Yasufuku K, Pierre A, Donahoe L, Wakeam E et al: Analysis of outcomes in resected early-stage NSCLC with rare targetable driver mutations. Ther Adv Med Oncol 2024, 16:17588359241308466.

6. Chan SWS, Zeng J, Young J, Barghout SH, Al-Agha F, Raptis S, Brown MC, Liu G, Juergens R, Jao K: A poor prognostic ALK phenotype: A review of molecular markers of poor prognosis in ALK re-arranged non-small cell lung cancer. Clinical lung cancer 2024.

7. Barghout SH, Zhan LJ, Raptis S, Al-Agha F, Esfahanian N, Popovacki A, Kasymjanova G, Proulx-Rocray F, Chan SWS, Richardson M et al: Treatment patterns and outcomes in KRAS(G12C)-positive advanced NSCLC patients previously treated with immune checkpoint inhibitors: A Canada-wide real-world, multi-center, retrospective cohort study. Lung Cancer 2024, 194:107898.

8. Barghout SH, Meti N, Chotai S, Kim CJH, Patel D, Brown MC, Hueniken K, Zhan LJ, Raptis S, Al-Agha F et al: Adaptive Universal Principles for Real-world Observational Studies (AUPROS): an approach to designing real-world observational studies for clinical, epidemiologic, and precision oncology research. Br J Cancer 2024.

9. Lee JJW, Kunaratnam V, Kim CJH, Pienkowski M, Hueniken K, Sahovaler A, Lam ACL, Davies JC, Brown CM, De Almeida JR et al: Cigarette smoking cessation, duration of smoking abstinence, and head and neck squamous cell carcinoma prognosis. Cancer 2023.

10. Zeuge U, Fares AF, Soriano J, Hueniken K, Bajwa J, Wang W, Schmid S, Rudolph-Naiberg S, Brown MC, Yeung J et al: Differential prognostic significance of sarcopenia in metastatic esophageal squamous and adenocarcinoma. Esophagus 2023.

11. Lee JJW, Kunaratnam V, Kim CJH, Pienkowski M, Hueniken K, Sahovaler A, Lam ACL, Davies JC, Brown CM, De Almeida JR et al: Cigarette smoking cessation, duration of smoking abstinence, and head and neck squamous cell carcinoma prognosis. Cancer 2023, 129(6):867-877.

12. Fares AF, Li Y, Jiang M, Brown MC, Lam ACL, Aggarwal R, Schmid S, Leighl NB, Shepherd FA, Wang Z et al: Association between duration of smoking abstinence before non-small-cell lung cancer diagnosis and survival: a retrospective, pooled analysis of cohort studies. The Lancet Public Health 2023, 8(9):e691-e700.

13. Esfahanian N, Chan SWS, Zhan LJ, Brown MC, Khan K, Lee J, Balaratnam K, Yan E, Parker J, Garcia-Pardo M et al: Presentation and outcomes of KRASG12C mutant non-small cell lung cancer patients with stage IV disease at diagnosis (de novo) versus at recurrence. Cancer Treatment and Research Communications 2023, 37:100774.

14. Weiss J, Pham NA, Pintilie M, Li M, Liu G, Shepherd FA, Tsao MS, Xu W: Optimizing Drug Response Study Design in Patient-Derived Tumor Xenografts. Cancer Inform 2022, 21:11769351221136056.

15. Schmid S, Zhan L, Dietrich K, Khan K, Chowdhury M, Herman M, Patel D, Zaeimi F, Leighl NB, Sacher A et al: Treatment Patterns and Outcomes of Patients With Advanced Pleural Mesothelioma at an Academic Referral Centre. Clinical lung cancer 2022, 23(1):e43-e53.

16. Schmid S, Jiang M, Brown MC, Fares A, Garcia M, Soriano J, Dong M, Thomas S, Kohno T, Leal LF et al: Accounting for EGFR Mutations in Epidemiologic Analyses of Non-Small Cell Lung Cancers: Examples Based on the International Lung Cancer Consortium Data. Cancer Epidemiol Biomarkers Prev 2022, 31(3):679-687.

17. Schmid S, Garcia M, Cheng S, Zhan L, Chotai S, Balaratnam K, Khan K, Patel D, Catherine Brown M, Sachdeva R et al: Treatment patterns and outcomes in early-stage ALK-rearranged non-small cell lung cancer. Lung Cancer 2022, 166:58-62.

18. Schmid S, Cheng S, Chotai S, Garcia M, Zhan L, Hueniken K, Balaratnam K, Khan K, Patel D, Grant B et al: Real-World Treatment Sequencing, Toxicities, Health Utilities, and Survival Outcomes in Patients with Advanced ALK-Rearranged Non-Small-Cell Lung Cancer. Clinical lung cancer 2022.

19. Ren J, Pang W, Luo Y, Cheng D, Qiu K, Rao Y, Zheng Y, Dong Y, Peng J, Hu Y et al: Impact of Allergic Rhinitis and Asthma on COVID-19 Infection, Hospitalization, and Mortality. The journal of allergy and clinical immunology in practice (Cambridge, MA) 2022, 10(1):124-133.

20. Ren J, Pang W, Hueniken K, Haddad G, Hope A, Huang SH, Spreafico A, Hansen AR, Perez‐Ordonez B, Goldstein DP et al: Longitudinal health utility and symptom‐toxicity trajectories in patients with head and neck cancers. Cancer 2022, 128(3):497-508.

21. Kuehne N, Hueniken K, Xu M, Shakik S, Vedadi A, Pinto D, Brown MC, Bradbury PA, Shepherd FA, Sacher AG et al: Longitudinal Assessment of Health Utility Scores, Symptoms and Toxicities in Patients with Small Cell Lung Cancer Using Real World Data. Clinical lung cancer 2022, 23(2):e154-e164.

22. Haddad G, Hueniken K, Xu MC, Bratman S, de Almeida J, Goldstein D, Huang SH, Hansen A, Hope A, Spreafico A et al: Association of post-treatment longitudinal symptom severity clusters with subsequent survival in oropharyngeal cancer. Head Neck 2022, 44(10):2181-2196.

23. Garcia-Pardo M, Czarnecka K, Law JH, Salvarrey A, Fernandes R, Fan J, Corke L, Waddell TK, Yasufuku K, Donahoe LL et al: Plasma-first: accelerating lung cancer diagnosis and molecular profiling through liquid biopsy. Therapeutic advances in medical oncology 2022, 14:17588359221126151-17588359221126151.

24. García-Pardo M, Chang A, Schmid S, Dong M, Brown MC, Christiani D, Tindel HA, Brennan P, Chen C, Zhang J et al: Respiratory and cardiometabolic comorbidities and Stage I-III non-small cell lung cancer (NSCLC) survival: A pooled analysis from the International Lung Cancer Consortium (ILCCO). Journal of Thoracic Oncology 2022.

25. Sung MR, Tomasini P, Le LW, Kamel-Reid S, Tsao M-S, Liu G, Bradbury PA, Shepherd FA, Li JJN, Feld R et al: Effects of Ethnicity on Outcomes of Patients With EGFR Mutation–Positive NSCLC Treated With EGFR Tyrosine Kinase Inhibitors and Surgical Resection. JTO clinical and research reports 2022, 3(2):100259-100259.

26. Zazuli Z, de Jong C, Xu W, Vijverberg SJH, Masereeuw R, Patel D, Mirshams M, Khan K, Cheng D, Ordonez-Perez B et al: Association between Genetic Variants and Cisplatin-Induced Nephrotoxicity: A Genome-Wide Approach and Validation Study. Journal of personalized medicine 2021, 11(11):1233.

27. Xu Y, Yang W, Song Y, Cheng D, Cao M, Huang J, Ren J, Lee JW, Hueniken K, Chen Y et al: Association of gastro-oesophageal reflux disease and quality of life in patients with chronic rhinosinusitis. Acta Otorhinolaryngol Ital 2021, 41(5):450-460.

28. Vedadi, A., S. Shakik, M.C. Brown, B.H. Lok, F.A. Shepherd, N.B. Leighl, A. Sacher, P.A. Bradbury, W. Xu, G. Liu, and G.M. O'Kane, The impact of symptoms and comorbidity on health utility scores and health-related quality of life in small cell lung cancer using real world data. Qual Life Res, 2021. 30(2): p. 445-454.

29. Schmid, S., L. Zhan, K. Dietrich, K. Khan, M. Chowdhury, M. Herman, D. Patel, F. Zaeimi, N.B. Leighl, A. Sacher, R. Feld, F.A. Shepherd, L. Donahoe, M. de Perrot, B.C.J. Cho, G. Liu, and P.A. Bradbury, Treatment Patterns and Outcomes of Patients With Advanced Pleural Mesothelioma at an Academic Referral Centre. Clin Lung Cancer, 2021.

30. Lau SCM, Ryan M, Weiss J, Fares AF, Garcia M, Schmid S, Kuang S, Kelly D, Tsao MS, Bradbury PA et al: Concurrent Chemoradiation With or Without Durvalumab in Elderly Patients With Unresectable Stage III NSCLC: Safety and Efficacy. JTO Clin Res Rep 2021, 2(12):100251.

31. Lau SCM, Fares AF, Le LW, Mackay KM, Soberano S, Chan SW, Smith E, Ryan M, Tsao MS, Bradbury PA, Pal P, Shepherd FA, Liu G, Leighl NB, Sacher AG. Subtypes of EGFR- and HER2-Mutant Metastatic NSCLC Influence Response to Immune Checkpoint Inhibitors. Clinical lung cancer 2021; 22(4): 253-9.

32. Khan, M.N., K. Hueniken, M. Manojlovic-Kolarski, L. Eng, M. Mirshams, K. Khan, C. Simpson, M. Au, G. Liu, W. Xu, C.J. Longo, D.P. Goldstein, J. Ringash, R. Martino, A.R. Hansen, and J.R. de Almeida, Out-of-pocket costs associated with head and neck cancer treatment. Cancer Rep (Hoboken), 2021: p. e1528.

33. Jiang, M., A.F. Fares, D. Shepshelovich, P. Yang, D. Christiani, J. Zhang, K. Shiraishi, B.M. Ryan, C. Chen, A.G. Schwartz, A. Tardon, S. Shete, M.B. Schabath, M.D. Teare, L. Le Marchand, Z.-F. Zhang, J.K. Field, H. Brenner, N. Diao, J. Xie, T. Kohno, C.C. Harris, A.S. Wenzlaff, G. Fernandez-Tardon, Y. Ye, F. Taylor, L.R. Wilkens, M. Davies, Y. Liu, M.J. Barnett, G.E. Goodman, H. Morgenstern, B. Holleczek, S. Thomas, M.C. Brown, R.J. Hung, W. Xu, and G. Liu, The relationship between body-mass index and overall survival in non-small cell lung cancer by sex, smoking status, and race: A pooled analysis of 20,937 International lung Cancer consortium (ILCCO) patients. Lung Cancer, 2021. 152: p. 58-65.

34. Herman, M., Z. Liu, F.A. Shepherd, N. Leighl, G. Liu, and P.A. Bradbury, The effect of prior cancer on non-small cell lung cancer trial eligibility. Cancer Med, 2021. 10(14): p. 4814-4822.

35. de Oliveira Faria S, Hurwitz G, Kim J, Liberty J, Orchard K, Liu G, Barbera L, Howell D. Identifying Patient-Reported Outcome Measures (PROMs) for Routine Surveillance of Physical and Emotional Symptoms in Head and Neck Cancer Populations: A Systematic Review. Journal of clinical medicine 2021; 10(18).

36. Chan, S.W.S., E. Smith, R. Aggarwal, K. Balaratnam, R. Chen, K. Hueniken, R. Fazelzad, J. Weiss, S. Jiang, F.A. Shepherd, P.A. Bradbury, A.G. Sacher, N.B. Leighl, W. Xu, M.C. Brown, L. Eng, and G. Liu, Systemic Inflammatory Markers of Survival in Epidermal Growth Factor-Mutated Non-Small-Cell Lung Cancer: Single-Institution Analysis, Systematic Review, and Meta-analysis. Clin Lung Cancer, 2021.

37. Bender, J.L., K. Hueniken, L. Eng, M.C. Brown, S. Kassirian, I. Geist, K. Balaratnam, M. Liang, C.B. Paulo, A. Geist, P. Rao, A. Magony, E.C. Smith, W. Xu, G. Liu, and A.A. Gupta, Internet and social media use in cancer patients: association with distress and perceived benefits and limitations. Supportive Care in Cancer, 2021.

38. Xu, Y., Y. Zheng, M. Cao, W. Yang, J. Ren, Y. Song, D. Cheng, J. Wang, L. Huang, W. Xu, Y. Zhao, and G. Liu, Association of Single-Nucleotide Polymorphisms With Chronic Rhinosinusitis in a Southwestern Han Chinese Population: A Replication Study. Am J Rhinol Allergy, 2020. 34(3): p. 352-360.

39. Schmid, S., E.L. Stewart, S.N. Martins-Filho, M. Cabanero, A. Wang, H. Bao, X. Wu, D. Patel, Z. Chen, J.H. Law, P.A. Bradbury, F.A. Shepherd, N. Leighl, M.S. Tsao, T. Pugh, S.V. Bratman, A. Sacher, and G. Liu, Early Detection of Multiple Resistance Mechanisms by ctDNA Profiling in a Patient With EGFR-mutant Lung Adenocarcinoma Treated With Osimertinib. Clin Lung Cancer, 2020. 21(5): p. e488-e492.

40. Ren, J., W. Xu, J. Su, X. Ren, D. Cheng, Z. Chen, N. Bender, M. Mirshams, S. Habbous, J.R. de Almeida, B. Perez-Ordonez, D.P. Goldstein, J.R. Wang, S.V. Bratman, S.H. Huang, R. Jang, Y. Zhao, T. Waterboer, R.J. Hung, and G. Liu, Multiple imputation and clinico-serological models to predict human papillomavirus status in oropharyngeal carcinoma: An alternative when tissue is unavailable. Int J Cancer, 2020. 146(8): p. 2166-2174.

41. Ren, J., X. Jing, J. Wang, X. Ren, Y. Xu, Q. Yang, L. Ma, Y. Sun, W. Xu, N. Yang, J. Zou, Y. Zheng, M. Chen, W. Gan, T. Xiang, J. An, R. Liu, C. Lv, K. Lin, X. Zheng, F. Lou, Y. Rao, H. Yang, K. Liu, G. Liu, T. Lu, X. Zheng, and Y. Zhao, Automatic Recognition of Laryngoscopic Images Using a Deep-Learning Technique. Laryngoscope, 2020. 130(11): p. E686-e693.

42. Lee, M.J., K. Hueniken, N. Kuehne, L. Lu, S.X. Jiang, B. Id Said, A. McCartney, Y. Gao, M. Liang, T. Obuobi, H. Sorotsky, L. Eng, M.C. Brown, W. Xu, and G. Liu, Cancer Patient-Reported Preferences and Knowledge for Liquid Biopsies and Blood Biomarkers at a Comprehensive Cancer Center. Cancer Manag Res, 2020. 12: p. 1163-1173.

43. Kuehne N, Hueniken K, Xu W, Shakik S, Vedadi A, Pinto D, Brown M, Bradbury P, Shepherd F, Sacher A et al: Predictors of and longitudinal assessment of health utility scores in patients with small cell lung cancer using real-world data. In: Journal of Clinical Oncology. vol. 38; 2020: e19306-e19306.

44. Haddad G, Schouwenburg S, Altesha A, Xu W, Liu G: Using breath analysis as a screening tool to detect gastric cancer: a systematic review. Journal of breath research 2020, 15(1).

45. Eng, L., J. Bender, K. Hueniken, S. Kassirian, L. Mitchell, R. Aggarwal, C. Paulo, E.C. Smith, I. Geist, K. Balaratnam, A. Magony, M. Liang, D. Yang, J.M. Jones, M.C. Brown, W. Xu, S.C. Grover, S.M.H. Alibhai, G. Liu, and A.A. Gupta, Age differences in patterns and confidence of using internet and social media for cancer-care among cancer survivors. Journal of Geriatric Oncology, 2020. 11(6): p. 1011-1019.

46. Eng, L., D. Alton, Y. Song, J. Su, Q. Zhang, J. Che, D. Farzanfar, R. Mohan, O. Krys, K. Mattina, C. Harper, S. Liu, T. Yoannidis, R. Milne, N. Abdelmutti, M.C. Brown, A. Vennettilli, A.J. Hope, D. Howell, J.M. Jones, P. Selby, W.K. Evans, W. Xu, D.P. Goldstein, M.E. Giuliani, and G. Liu, Awareness of the Harms of Continued Smoking Among Cancer Survivors. Support Care Cancer, 2020. 28(7): p. 3409-3419.

47. Aggarwal, R., K. Hueniken, L. Eng, S. Kassirian, I. Geist, K. Balaratnam, M. Liang, C.B. Paulo, A. Geist, P. Rao, L. Mitchell, A. Magony, J.M. Jones, S.C. Grover, M.C. Brown, J. Bender, W. Xu, G. Liu, and A.A. Gupta, Health-related social media use and preferences of adolescent and young adult cancer patients for virtual programming. Supportive Care in Cancer, 2020. 28(10): p. 4789-4801.